{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:07:59Z","timestamp":1785409679301,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K23 EY033438-01"],"award-info":[{"award-number":["K23 EY033438-01"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014275","name":"Parkinson Study Group","doi-asserted-by":"publisher","award":["Mentored Clinical Research Award"],"award-info":[{"award-number":["Mentored Clinical Research Award"]}],"id":[{"id":"10.13039\/100014275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS099129-05"],"award-info":[{"award-number":["R01 NS099129-05"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40266-022-00991-6","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:27:11Z","timestamp":1669976831000},"page":"967-974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hallucinations, Antipsychotic Use, and Mortality in Older Adults with Dementia: Retrospective Cohort Study of Two Medicare-Linked National Health Surveys"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5949-6395","authenticated-orcid":false,"given":"Ali G.","family":"Hamedani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison W.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"991_CR1","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1176\/appi.ajp.162.11.2022","volume":"162","author":"SA Ropacki","year":"2005","unstructured":"Ropacki SA, Jeste DV. Epidemiology of and risk factors for psychosis of Alzheimer\u2019s disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry. 2005;162:2022\u201330.","journal-title":"Am J Psychiatry"},{"key":"991_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.25389","volume":"28","author":"K Zhu","year":"2013","unstructured":"Zhu K, van Hilten JJ, Putter H, Marinus J. Risk factors for hallucinations in Parkinson\u2019s disease: results from a large prospective cohort study. Mov Disord Off J Mov Disord Soc. 2013;28:755\u201362.","journal-title":"Mov Disord Off J Mov Disord Soc."},{"key":"991_CR3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1001\/jamaneurol.2013.3579","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol. 2013;70:1396\u2013402.","journal-title":"JAMA Neurol"},{"key":"991_CR4","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","volume":"294","author":"LS Schneider","year":"2005","unstructured":"Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934\u201343.","journal-title":"JAMA"},{"key":"991_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/archinternmed.2009.456","volume":"170","author":"ER Dorsey","year":"2010","unstructured":"Dorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC. Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med. 2010;170:96\u2013103.","journal-title":"Arch Intern Med"},{"issue":"123","key":"991_CR6","first-page":"349","volume":"2005","author":"GJ Menon","year":"1960","unstructured":"Menon GJ. Complex visual hallucinations in the visually impaired: a structured history-taking approach. Arch Ophthalmol Chic Ill. 1960;2005(123):349\u201355.","journal-title":"Arch Ophthalmol Chic Ill"},{"key":"991_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/mds.22868","volume":"25","author":"KR Chaudhuri","year":"2010","unstructured":"Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, et al. The nondeclaration of nonmotor symptoms of Parkinson\u2019s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord Off J Mov Disord Soc. 2010;25:704\u20139.","journal-title":"Mov Disord Off J Mov Disord Soc."},{"key":"991_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/JGP.0b013e31819b8936","volume":"17","author":"L Simoni-Wastila","year":"2009","unstructured":"Simoni-Wastila L, Ryder PT, Qian J, Zuckerman IH, Shaffer T, Zhao L. Association of antipsychotic use with hospital events and mortality among medicare beneficiaries residing in long-term care facilities. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2009;17:417\u201327.","journal-title":"Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry."},{"key":"991_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","volume":"72","author":"DT Maust","year":"2015","unstructured":"Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiat. 2015;72:438\u201345.","journal-title":"JAMA Psychiat"},{"key":"991_CR10","doi-asserted-by":"publisher","first-page":"153331752210813","DOI":"10.1177\/15333175221081374","volume":"37","author":"N Rashid","year":"2022","unstructured":"Rashid N, Wetmore JB, Irfan M, Abler V. Adverse outcomes associated with off-label agents used to treat dementia patients with psychosis: a case-control medicare database study. Am J Alzheimers Dis Other Demen. 2022;37:15333175221081374.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"991_CR11","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1176\/appi.ajp.2007.06101710","volume":"164","author":"HC Kales","year":"2007","unstructured":"Kales HC, Valenstein M, Kim HM, McCarthy JF, Ganoczy D, Cunningham F, et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry. 2007;164:1568\u201376 (quiz 1623).","journal-title":"Am J Psychiatry"},{"key":"991_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/jgs.13326","volume":"63","author":"Y Park","year":"2015","unstructured":"Park Y, Franklin JM, Schneeweiss S, Levin R, Crystal S, Gerhard T, et al. Antipsychotics and mortality: adjusting for mortality risk scores to address confounding by terminal illness. J Am Geriatr Soc. 2015;63:516\u201323.","journal-title":"J Am Geriatr Soc"},{"key":"991_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jagp.2021.07.018","volume":"30","author":"AG Hamedani","year":"2022","unstructured":"Hamedani AG, Weintraub D, Willis AW. Medicare claims data underestimate hallucinations in older adults with dementia. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2022;30:352\u20139.","journal-title":"Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry."},{"key":"991_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mdc3.12479","volume":"4","author":"KA Holiday","year":"2017","unstructured":"Holiday KA, Pirogovsky-Turk E, Malcarne VL, Filoteo JV, Litvan I, Lessig SL, et al. Psychometric properties and characteristics of the north-east visual hallucinations interview in Parkinson\u2019s disease. Mov Disord Clin Pract. 2017;4:717\u201323.","journal-title":"Mov Disord Clin Pract."},{"key":"991_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/aos.14287","volume":"98","author":"S Niazi","year":"2020","unstructured":"Niazi S, Krogh Nielsen M, Singh A, S\u00f8rensen TL, Subhi Y. Prevalence of Charles Bonnet syndrome in patients with age-related macular degeneration: systematic review and meta-analysis. Acta Ophthalmol (Copenh). 2020;98:121\u201331.","journal-title":"Acta Ophthalmol (Copenh)."},{"key":"991_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.jagp.2013.01.051","volume":"21","author":"J Vilalta-Franch","year":"2013","unstructured":"Vilalta-Franch J, L\u00f3pez-Pousa S, Calv\u00f3-Perxas L, Garre-Olmo J. Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2013;21:1135\u201343.","journal-title":"Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry."},{"key":"991_CR17","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1001\/archneur.62.10.1601","volume":"62","author":"N Scarmeas","year":"2005","unstructured":"Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol. 2005;62:1601\u20138.","journal-title":"Arch Neurol"},{"key":"991_CR18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/156720512803569037","volume":"9","author":"V Gardette","year":"2012","unstructured":"Gardette V, Lapeyre-Mestre M, Coley N, Cantet C, Montastruc J-L, Vellas B, et al. Antipsychotic use and mortality risk in community-dwelling Alzheimer\u2019s disease patients: evidence for a role of dementia severity. Curr Alzheimer Res. 2012;9:1106\u201316.","journal-title":"Curr Alzheimer Res"},{"key":"991_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000090251","volume":"26","author":"RS Wilson","year":"2006","unstructured":"Wilson RS, Tang Y, Aggarwal NT, Gilley DW, McCann JJ, Bienias JL, et al. Hallucinations, cognitive decline, and death in Alzheimer\u2019s disease. Neuroepidemiology. 2006;26:68\u201375.","journal-title":"Neuroepidemiology"},{"key":"991_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3233\/JAD-150946","volume":"52","author":"MH Connors","year":"2016","unstructured":"Connors MH, Ames D, Boundy K, Clarnette R, Kurrle S, Mander A, et al. Predictors of mortality in dementia: the PRIME Study. J Alzheimers Dis JAD. 2016;52:967\u201374.","journal-title":"J Alzheimers Dis JAD."},{"key":"991_CR21","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/archneur.56.10.1266","volume":"56","author":"OL Lopez","year":"1999","unstructured":"Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol. 1999;56:1266\u201372.","journal-title":"Arch Neurol"},{"key":"991_CR22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1001\/jamaneurol.2021.2943","volume":"78","author":"SS Mooldijk","year":"2021","unstructured":"Mooldijk SS, Licher S, Wolters FJ. characterizing demographic, racial, and geographic diversity in dementia research: a systematic review. JAMA Neurol. 2021;78:1255\u201361.","journal-title":"JAMA Neurol"},{"key":"991_CR23","unstructured":"NHATS Public Use Data. Rounds 1-7. Sponsored by the National Institute on Aging (grant number NIA U01AG032947) through a cooperative agreement with the Johns Hopkins Bloomberg School of Public Health. www.nhats.org. Accessed 14 Mar 2019."},{"key":"991_CR24","unstructured":"Harnonized HRS Dataset and Codebook Version B, October 2018. Developed by the Gateway to Global Aging Data, funded by the National Institute on Aging (R01 AG030153 RC2 AG036619, 1R03Ag043052). www.g2aging.org. Accessed 14 Mar 2019."},{"key":"991_CR25","unstructured":"Kasper J, Freedman V, Spillman B. Classification of Persons by Dementia Status in the National Health and Aging Trends Study. Technical Pper #5. Baltim Johns Hopkins Bloom Sch Public Health. 2013;"},{"key":"991_CR26","volume-title":"Langa-Weir Classification of Cognitive Function (1995 Onward)","author":"K Langa","year":"2020","unstructured":"Langa K, Weir D, Kabeto M, Sonnega A. Langa-Weir Classification of Cognitive Function (1995 Onward). Survey Research Center, Institute for Social Research, University of Michigan; 2020."},{"key":"991_CR27","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/jgs.16054","volume":"67","author":"KL Harrison","year":"2019","unstructured":"Harrison KL, Ritchie CS, Patel K, Hunt LJ, Covinsky KE, Yaffe K, et al. Care settings and clinical characteristics of older adults with moderately severe dementia. J Am Geriatr Soc. 2019;67:1907\u201312.","journal-title":"J Am Geriatr Soc"},{"key":"991_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.295.7.801","volume":"295","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295:801\u20138.","journal-title":"JAMA"},{"key":"991_CR29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/jgs.12730","volume":"62","author":"HC Kales","year":"2014","unstructured":"Kales HC, Gitlin LN, Lyketsos CG, Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia. Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc. 2014;62:762\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"991_CR30","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/brain\/awq001","volume":"133","author":"RA Sweet","year":"2010","unstructured":"Sweet RA, Bennett DA, Graff-Radford NR, Mayeux R, National Institute on Aging Late-Onset Alzheimer\u2019s Disease Family Study Group. Assessment and familial aggregation of psychosis in Alzheimer\u2019s disease from the National Institute on Aging Late Onset Alzheimer\u2019s Disease Family Study. Brain J Neurol. 2010;133:1155\u201362.","journal-title":"Brain J Neurol."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00991-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-022-00991-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00991-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T18:07:06Z","timestamp":1670522826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-022-00991-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1007\/s40266-022-00991-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"20 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the NIH (K23 EY033438-01 to AGH, R01 NS099129-05 to AWW), Parkinson Study Group (Mentored Clinical Research Award to AGH), and Acadia Pharmaceuticals (investigator-initiated award to AWW and DW). The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Drs. Hamedani, Weintraub, and Willis declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the University of Pennsylvania Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from participants in the National Health and Aging Trends Study and Health and Retirement Study at the time of enrollment.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data that support the findings of this study are available from the National Health and Aging Trends Study, Health and Retirement Study, and Centers for Medicare and Medicaid Services, but restrictions apply to the availability of some of these data, which were used under license for the current study, and so are not publicly available.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The analytic code used to support the findings in this study are available from the corresponding author upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Dr. Hamedani conceived of the study, performed the primary statistical analysis, and drafted the manuscript. Drs. Weintraub and Willis provided input in study design, results interpretation, and critical manuscript review. Dr. Hamedani had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors have read and approved the final submitted manuscript and agree to be accountable for this work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}